Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity

Table 2

Mean ± SEM values of clinical, metabolic, and hormonal values in the two subgroups of heart failure, with preserved or reduced ejection fraction (HFpEF and HFrEF, respectively).

	HFpEF	HFrEF
NHYA class	II (n = 12)	II (n = 10)
	III (n = 18)	III (n = 10)
NT-proBNP (pg/ml)	2862.2 ± 488.5	7500.16 ± 2459.5	<0.05
Total cholesterol (mg/dl)	125.5 ± 6.9	153.6 ± 10.9	<0.05
HDL-C (mg/dl)	34.4 ± 2	44.47 ± 5.2	n.s.
LDL-C (mg/dl)	75.7 ± 7.3	91.36 ± 7.3	n.s.
Creatinine (mg/dl)	1.3 ± 0.1	1.27 ± 0.1	n.s.
Insulin (μUI/ml)	11.8 ± 1.4	25.32 ± 9.9	n.s.
Glucose (mg/dl)	88.5 ± 4.7	94.95 ± 8.4	n.s.
HOMA-IR	2.8 ± 0.5	3.68 ± 1.3	n.s.
BMI (kg/m^2)	28.7 ± 1.1	28.03 ± 1.2	n.s.
IGF-1 (ng/ml)	89.4 ± 7.1	112.78 ± 11.8	n.s.
DHEA-S (ng/ml)	438.9 ± 61.1	564.1 ± 140.3	n.s.
TSH (μU/ml)	2.5 ± 0.5	2.82 ± 1.0	n.s.
fT3 (pg/ml)	2.4 ± 0.1	2.5 ± 0.1	n.s.
fT4 (pg/ml)	11.3 ± 0.5	11.28 ± 0.5	n.s.
T (ng/ml)	2.4 ± 0.2	3.55 ± 0.5	<0.05
LAG (sec)	83 ± 6.7	75.77 ± 7.5	n.s.